Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dike Ojji

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
BMJ Open|December 22, 2022
Stakeholder perspectives on the demand and supply factors driving substandard and falsified blood pressure lowering medications in Nigeria: a qualitative studyGrace Shedul, Olutobi Adekunle Sanuade, Eugenia N Ugwuneji, et al.
Frontiers in Public Health|January 1, 2026
Advancing public health leadership through culturally centered and responsive research mentorship training in NigeriaRifkatu Reng, Manmak Mamven, Fatima Kyari, et al.
JACC. Advances|June 24, 2025
Low-Dose Combinations With 3 or 4 Blood Pressure-Lowering Medications for the Treatment of HypertensionNelson Wang, Phidias Rueter, Abdul Salam, et al.
Global Health Research and Policy|September 14, 2024
Moving forward: scaling-up the integration of an HIV and hypertension program in Akwa Ibom State, NigeriaShivani Mishra, Angela A Aifah, Daniel Henry, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in Sub-Saharan Africa: results from the THESUS-HF registryClovis Nkoke, Albertino Damasceno, Christopher Edwards, et al.
Implementation Science Communications|August 31, 2021
Stakeholder perspectives to inform adaptation of a hypertension treatment program in primary healthcare centers in the Federal Capital Territory, Nigeria: a qualitative studyRosemary C B Okoli, Gabriel Shedul, Lisa R Hirschhorn, et al.
Plos One|January 8, 2025
An implementation trial to mAnage siCkle CELl disEase through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE): Study protocolEmmanuel Peprah, Joyce Gyamfi, John Patena, et al.
Global Heart|May 27, 2021
The World Heart Federation Global Study on COVID-19 and Cardiovascular DiseaseKaren Sliwa, Kavita Singh, Lana Raspail, et al.
Plos One|June 9, 2025
Comparison of WHO laboratory-based and non-laboratory-based CVD risk charts among hypertensive adults attending primary healthcare centers in West Africa sub-regionKojo Awotwi Hutton-Mensah, Olayinka Rasheed Ibrahim, Adaku Nwankwo, et al.
Journal of Human Hypertension|January 11, 2025
Red cell distribution width as a cardiovascular risk predictor in adults with hypertension in sub-Saharan AfricaOlayinka Rasheed Ibrahim, Kojo Awotwi Hutton-Mensah, Funmi Temidayo Adeniyi, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
BMJ Open|December 22, 2022
Stakeholder perspectives on the demand and supply factors driving substandard and falsified blood pressure lowering medications in Nigeria: a qualitative studyGrace Shedul, Olutobi Adekunle Sanuade, Eugenia N Ugwuneji, et al.
Frontiers in Public Health|January 1, 2026
Advancing public health leadership through culturally centered and responsive research mentorship training in NigeriaRifkatu Reng, Manmak Mamven, Fatima Kyari, et al.
JACC. Advances|June 24, 2025
Low-Dose Combinations With 3 or 4 Blood Pressure-Lowering Medications for the Treatment of HypertensionNelson Wang, Phidias Rueter, Abdul Salam, et al.
Global Health Research and Policy|September 14, 2024
Moving forward: scaling-up the integration of an HIV and hypertension program in Akwa Ibom State, NigeriaShivani Mishra, Angela A Aifah, Daniel Henry, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in Sub-Saharan Africa: results from the THESUS-HF registryClovis Nkoke, Albertino Damasceno, Christopher Edwards, et al.
Implementation Science Communications|August 31, 2021
Stakeholder perspectives to inform adaptation of a hypertension treatment program in primary healthcare centers in the Federal Capital Territory, Nigeria: a qualitative studyRosemary C B Okoli, Gabriel Shedul, Lisa R Hirschhorn, et al.
Plos One|January 8, 2025
An implementation trial to mAnage siCkle CELl disEase through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE): Study protocolEmmanuel Peprah, Joyce Gyamfi, John Patena, et al.
Global Heart|May 27, 2021
The World Heart Federation Global Study on COVID-19 and Cardiovascular DiseaseKaren Sliwa, Kavita Singh, Lana Raspail, et al.
Plos One|June 9, 2025
Comparison of WHO laboratory-based and non-laboratory-based CVD risk charts among hypertensive adults attending primary healthcare centers in West Africa sub-regionKojo Awotwi Hutton-Mensah, Olayinka Rasheed Ibrahim, Adaku Nwankwo, et al.
Journal of Human Hypertension|January 11, 2025
Red cell distribution width as a cardiovascular risk predictor in adults with hypertension in sub-Saharan AfricaOlayinka Rasheed Ibrahim, Kojo Awotwi Hutton-Mensah, Funmi Temidayo Adeniyi, et al.
Pageof 7